LDX
LUMOS DIAGNOSTICS ORDINARYLumos Diagnostics Holdings Limited develops, manufactures, and distributes diagnostic technologies in the United States. The company offers FebriDx, a point-of-care diagnostic test for acute respiratory infections, and ViraDx, a three-in-one point-of-care test for influenza A, influenza B, and COVID-19. It also provides assay development and manufacturing services for point-of-care tests and proprietary digital reader platforms. The company was incorporated in 2018 and is headquartered in Carlsbad, California.
LDX
LDX
LUMOS DIAGNOSTICS ORDINARY
Lumos Diagnostics Holdings Limited develops, manufactures, and distributes diagnostic technologies in the United States. The company offers FebriDx, a point-of-care diagnostic test for acute respiratory infections, and ViraDx, a three-in-one point-of-care test for influenza A, influenza B, and COVID-19.
Fundamentals
Historical Data47 days
| Date | Short % | Gross Short |
|---|---|---|
| 28 Aug | — | — |
| 27 Aug | — | — |
| 26 Aug | — | — |
| 25 Aug | 0.00% | — |
| 24 Aug | 0.00% | — |
| 21 Aug | 0.00% | — |
| 20 Aug | 0.00% | — |
| 19 Aug | 0.00% | — |
| 18 Aug | 0.00% | — |
| 17 Aug | 0.00% | — |
| 14 Aug | 0.00% | — |
| 13 Aug | 0.00% | — |
Lumos Diagnostics (LDX) Short Interest Summary
Lumos Diagnostics (LDX) currently has 0.00% of its shares sold short (24 thousand shares, worth approximately $2K), based on ASIC short position data reported on 25 August 2026 (T+4 reporting lag). That makes LDX the #614 most shorted stock on the ASX most shorted list. Short interest in LDX is up 0.00% over the past week. LDX is part of the Health Care sector on the ASX.
Recent LDX Short Position History
| Date | Short % | Short Shares | Close Price |
|---|---|---|---|
| 25 Aug 2026 | 0.00% | 0.0M | $0.10 |
| 24 Aug 2026 | 0.00% | 0.0M | $0.10 |
| 21 Aug 2026 | 0.00% | 0.0M | $0.10 |
| 20 Aug 2026 | 0.00% | 0.0M | $0.10 |
| 19 Aug 2026 | 0.00% | 0.0M | $0.10 |
| 18 Aug 2026 | 0.00% | 0.0M | $0.11 |
| 17 Aug 2026 | 0.00% | 0.0M | $0.12 |
| 14 Aug 2026 | 0.00% | 0.0M | $0.11 |
| 13 Aug 2026 | 0.00% | 0.0M | $0.12 |
| 12 Aug 2026 | 0.00% | 0.0M | $0.12 |
LDX Short Selling — Frequently Asked Questions
What is Lumos Diagnostics (LDX)'s current short interest?
Lumos Diagnostics (LDX) currently has a short interest of 0.00% of total shares outstanding. This means 0.00% of LDX's shares have been sold short by investors who expect the price to decline. This data is sourced from ASIC reports and updated daily.
Is LDX heavily shorted on the ASX?
LDX has a relatively low short interest of 0.00%. Short interest below 5% generally suggests limited bearish sentiment from short sellers.
What does short interest mean for LDX investors?
Short interest in LDX shows the percentage of shares investors have borrowed and sold, betting the price will fall. At 0.00%, LDX's short interest is at a low level. See our short squeeze candidates and days to cover analysis for more context.
Where does this LDX short data come from?
Short position data is published by ASIC with a four trading day delay (T+4) and covers reported short positions as a percentage of total shares on issue. ASX Short Data also tracks daily gross short sales (T+1), securities lending, and director trades for LDX.